<DOC>
	<DOCNO>NCT00315055</DOCNO>
	<brief_summary>To demonstrate immune response hepatitis B antigen DTaP-IPV-Hep B-PRP~T non-inferior association PENTAXIM™ ENGERIX B® one month three dose ( 2-3-4 month ) primary series . Immunogenicity - To assess pre- post-primary series - To assess pre- post-booster series .</brief_summary>
	<brief_title>Immunogenicity DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ ENGERIX B® 2-3-4 Months Schedule</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Twomonth old infant either gender day inclusion Born full term pregnancy ( &gt; =37 week ) birth weight &gt; =2.5 kg Informed consent form sign parent ( ) legal representative ( ) institution official investigator Able attend schedule visit comply trial procedure . Participation another clinical trial 4 week precede first trial vaccination Planned participation another clinical trial present trial period Congenital acquire immunodeficiency , immunosuppressive therapy longterm systemic corticosteroid therapy Systemic hypersensitivity vaccine component history life threaten reaction vaccine contain substance Chronic illness stage could interfere trial conduct completion Blood bloodderived product receive since birth Any vaccination ( except BCG ) 4 week precede first trial vaccination Vaccination plan 4 week follow trial vaccination History document pertussis , tetanus , diphtheria , polio , Haemophilus influenzae type b hepatitis B infection ( ) ( confirm either clinically , serologically microbiologically ) Known personal maternal history HIV , Hepatitis B Hepatitis C seropositivity Previous vaccination pertussis , tetanus , diphtheria , polio Hib , HB infection ( ) Coagulopathy , thrombocytopenia bleed disorder contraindicate intramuscular vaccination History seizure Febrile ( axillary temperature 37.4°C [ rectal equivalent temperature &gt; =38.0°C ] ) acute illness day inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>50 Days</minimum_age>
	<maximum_age>71 Days</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Polio</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Pertussis</keyword>
	<keyword>H influenzae type b</keyword>
</DOC>